Editorial: Drug Discovery for Neglected Diseases

Curr Top Med Chem. 2018;18(5):313-314. doi: 10.2174/156802661805180611112621.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Animals
  • Anti-Infective Agents / chemical synthesis
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology*
  • Antimalarials / chemical synthesis
  • Antimalarials / chemistry
  • Antimalarials / pharmacology*
  • Drug Discovery*
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Fatty Acids / chemical synthesis
  • Fatty Acids / chemistry
  • Fatty Acids / pharmacology
  • Fructose-Bisphosphate Aldolase / antagonists & inhibitors
  • Fructose-Bisphosphate Aldolase / metabolism
  • Humans
  • Models, Molecular
  • Neglected Diseases / drug therapy*
  • Plasmodium / drug effects
  • Polyamines / chemical synthesis
  • Polyamines / chemistry
  • Polyamines / pharmacology
  • Schistosoma mansoni / enzymology
  • Tetrahydrofolate Dehydrogenase / metabolism
  • Trypanocidal Agents / chemical synthesis
  • Trypanocidal Agents / chemistry
  • Trypanocidal Agents / pharmacology*
  • Trypanosoma brucei brucei / enzymology
  • Ubiquitin-Protein Ligases / antagonists & inhibitors
  • Ubiquitin-Protein Ligases / metabolism

Substances

  • Anti-Infective Agents
  • Antimalarials
  • Enzyme Inhibitors
  • Fatty Acids
  • Polyamines
  • Trypanocidal Agents
  • Tetrahydrofolate Dehydrogenase
  • Ubiquitin-Protein Ligases
  • Fructose-Bisphosphate Aldolase